Your program’s bill of materials reflects the product design intent, but it may not account for your contract manufacturer’s production realities. Any design changes due to manufacturability or commercialization issues could derail your innovation’s quickest, most resourceful path to market.
Analytical instruments, diagnostic platforms, and complex automation systems carry their own mix of components and subassemblies, all with different validation requirements. When a manufacturing expert’s perspective isn’t accounted for on the front end, your team can run into significant production setbacks.
Bringing your contract manufacturer into the conversation earlier, before design freeze, changes that dynamic entirely. For many programs, that shift starts with an early Build to Print engagement, where manufacturability input begins well before the print is finalized.
What Pre-Production Input Looks Like for Medical and Life Sciences Programs
Early engagement does not mean handing over an unfinished design and asking for open-ended feedback. With the right contract manufacturer, it should be a collaboration to develop structured touchpoints based on your exact product specifications. Without relevant application and engineering expertise, it can be hard to grasp which design decisions might disrupt the manufacturing schedule.
This typically includes touchpoints, such as:
- Design for manufacturability (DfM) review of draft prints, before tolerances are finalized
- Feasibility checks confirming the product materials and manufacturing processes are aligned with design, development, and launch plans
- Early input on component selection where standard parts could replace custom ones
- Scalability guidance to maintain quality and throughput across design transfers
You don’t need to have a finished design to seek out a contract manufacturer. If you’re willing to share work in progress, the right multidisciplinary team should be able to tweak and pressure-test your design, build a roadmap to regulated markets, and execute the manufacturing process.
Related Reading: FDA QMSR Explained: What Early-Stage Medical Device Companies Need to Know
The Risks of Waiting Until Print Release
Teams deep in a research, design, or prototyping stage are focused on the product’s function and performance, and the corresponding regulatory pathway, as they should be. Manufacturability is a different discipline, and it is easy to assume it will sort itself out downstream. In practice, waiting until print release tends to surface the same categories of problems, whether the end product is an implantable device or a benchtop analyzer:
- Tolerances that are realistic on paper but expensive or unreliable to hold in production
- Custom components where a validated standard part would have performed the same function
- Complex assembly sequences that work in a lab bench but do not translate to a repeatable, ISO-classified production environment
If these concerns sound familiar, that doesn’t mean that there is a lack of priorities. It’s only natural for innovators to stay focused on getting their product to function correctly and safely. Critical manufacturing considerations often sit outside the program team’s immediate view.
Related Reading: From Lab Prototype to Commercial-Ready: Minding the Commercialization Gap
What Your Contract Manufacturer Sees That You Can’t
A contract manufacturing partner brings a different vantage point, shaped by what has gone right and gone wrong across a wide range of medical and life sciences programs. Manufacturing partners are challenged to consider the trickle-down effect across the entire program to understand how design decisions influence everything from real-world application use to supply chain strategy.
While a tolerance adjustment on a draft print is a redline, the same adjustment after print release is a deviation that requires a rework cycle and potentially months of revalidation work. Early DfM input can shape the design while changes are still low-cost.
How Early Manufacturing Engagement Accelerates Time-to-Market
Programs that involve their contract manufacturer before design freeze typically see:
- Fewer late-stage design changes. Manufacturability issues get caught and resolved while they are still inexpensive to fix.
- Faster time to first article. A print that has already been reviewed for usability and producibility moves through initial builds with fewer surprises.
- Smoother transition to full production. Inspection methods, fixturing, and process steps are considered alongside the design instead of retrofitted to it.
- Stronger cGMP readiness. This matters for regulated medical devices and is increasingly expected for instrument platforms feeding into regulated workflows as well.
Where Expert Support Fits in Your Program
This is where a Build to Print engagement earns its place. In a traditional model, a contract manufacturer receives a finished print and builds to it. An early Build to Print engagement flips that timeline: Ascential’s team reviews draft prints for DfM, weighs in on component selection, and flags tolerance or process risks while the design can still absorb them.
For programs with more complex validation needs or component sourcing challenges, Build to Print Plus adds a deeper layer of engineering support, from process development to supply chain strategy, without asking your team to hand over ownership of the design. Either path treats print release as the milestone the design has already been prepared for, not the point where manufacturability questions start.
Related Reading: Build to Print vs. Build to Print Plus: Which Contract Manufacturing Approach Is Right for Your Medical Device?
Takeaway: Early Input Beats Expensive Deviations
Early engagement does not require a formal program overhaul. If you want to start with a review of an early design, or assess the DfM for an existing print, that’s a great starting point. Ascential’s team can tailor our expert insights to your program’s specific manufacturing needs.
Curious about how proactive design input can help you maximize your program’s resources? Bring Ascential’s experienced product development and manufacturing experts onboard early to ensure design changes don’t disrupt your program’s budget or schedule.
Before December 31, 2026, qualifying new customers can also lock in a 5-business-day BTP quote turnaround and 10% off their first order (up to $25,000).